Evercore ISI analyst Gavin Clark-Gartner raised the price target on Mirum Pharmaceuticals (NASDAQ: MIRM) to $76.00 (from $68.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE